WB

William Bill Burns

Mesoblast Limited | Non-Executive Director, Vice-Chairman
Mr. Burns has served on the Board of Directors since 2014 and was appointed Vice Chairman in 2016. He spent his management career at the Beecham Group and F. Hoffmann-La Roche Ltd. He was Chief Executive Officer of Roche Pharmaceuticals from 2001 to 2009, when he joined the Board of Directors of F. Hoffmann-La Roche Ltd. until he retired in 2014. He is the Chair of Molecular Partners, and has been a Non-Executive Director of Shire PLC, Chugai Pharmaceutical Co., Genentech, Crucell, and Chairman of Biotie Therapies Corp.

Company and Roles

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Non-Executive Director
  • Vice-Chairman
12yrs, 4mthMar 2014

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
21/10/2563,000226,250659,651N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
21/10/25
Issued
120,000$1.310$157,200Exercise of options
MSB
MSB
Mesoblast Limited
21/10/25
Exercise
120,000$1.310$157,200Exercise of options
MSB
MSB
Mesoblast Limited
09/01/25
Issued
150,000$2.810$421,500Issue of options
MSB
MSB
Mesoblast Limited
10/01/24
Issued
409,651$0.285$116,750Issue of options
MSB
MSB
Mesoblast Limited
28/12/23
Issued
21,250$0.300$6,375Rights issue